According to a recently published report by Research Nester on “3D Printed Oncology Prosthetics Market: Global Demand Analysis & Opportunity Outlook 2027” delivers detailed overview of the 3D printed oncology prosthetics market in terms of market segmentation by material, by end users and by region.

Further, for the in-depth analysis, the report encompasses the industry growth drivers, restraints, supply and demand risk, market attractiveness, BPS analysis and Porter’s five force model.

The global 3D printed oncology prosthetics market is anticipated to expand by a significant CAGR over the forecast period i.e. 2019-2027 owing to 3D printed tumor models’ ability to help the doctors and surgeons to get the better understanding of the cancer cells they are going to treat and remove from the patient’s body. It can also help the patients understand their own body conditions. This technology helps the doctors know more about cancer and how different types of cancer respond to different treatments. New applications in 3D printing are now being used in the medical field, whereas, researchers are focusing on developing printers that can print human tissue and even pills.

The market is segmented by material & end users. The material segment is further bifurcated into polypropylene, polyurethane, acrylics and polyethylene, and others, out of which, the polypropylene and polyethylene material segment is anticipated to have significant growth on account of their wide usability in the designing of the 3D printed prosthetic implants for various tumors.  On the basis of end users, the market is sub-segmented into medical & surgical centers, pharma & biotech companies, academic institutions, hospitals, rehabilitation centers and others.

The market in North America is anticipated to have largest share in 3D printed oncology prosthetics market owing to the rise in the incidences of cancer cases and growing number of accidental injuries in the region. The market in Asia Pacific region is expected to witness significant growth on account of rising awareness among people about the technological advancements pertaining to 3D printed oncology prosthetics in the region, whereas, the market in MEA and Latin America is anticipated to witness relative slow growth due to the absence of awareness among the patients in these regions.

Growing Incidences of Cancer Cases across the Globe

Among growing number of cancer cases around the world, the most common cancers are breast cancer, lungs cancer, liver cancer, bone cancer and others. According to National Cancer Institute, in 2018, around 17 lakh new cases were diagnosed in U.S. and around 6 lakh people died due to the disease. Additionally, the 3D printing technology has the benefit of designing the prosthetics according to the patient’s anatomy which makes the design more precise and real. These factors are anticipated to propel the market growth during the forecast period.

However, high cost of treatment and lack of awareness among people are estimated to operate as restraining factors to the growth of 3D printed oncology prosthetics market over the forecast period.

This report also provides the existing competitive scenario of some of the key players of the 3D printed oncology prosthetics market which includes company profiling of GE Healthcare, Xilloc Medical B.V., Koninklijke Philips N.V, 3D Life Prints Limited, and Canon Inc. The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the 3D printed oncology prosthetics market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.